[Neuroprotection therapy of multiple sclerosis with high doses of ethylmethylhydroxypyridine succinate].
To study the therapeutic action of ethylmethylhydroxypyridine succinate (mexidol) on the neurodegeneration in multiple sclerosis (MS). Fifty-two MS patients and 24 healthy controls were examined using DTI MRI with tractography. Ethylmethylhydroxypyridine succinate can prevent the progression of neurodegenerative processes in MS. However, further clinical trials are needed to confirm the results obtained in this study.